News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Montana BioScience Alliance
|
December 12, 2024

In recognition of her extraordinary contributions, Sharon has been inducted into the Montana Bioscience Hall of Fame, a fitting tribute to her enduring impact on our bioscience community. And to further honor her legacy, we are proud to announce the creation of the Sharon Peterson STEM Scholarship.

Gaize
|
September 5, 2024

Device developed by Missoula company Gaize (gaize.ai) could help to keep people safe at work and on the road.

C2M Beta
|
August 19, 2024

2M Beta is a 12-week program delivering the foundational and modern skills required to transform influential ideas into thriving businesses. With access to more professional expertise, more state-of-the-art technology and more community resources, C2M Beta was founded with the mission to connect local entrepreneurs to more!

Montana BioScience Alliance
|
July 25, 2024

A message from Board President Cynthia Tsai

SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in principle to create a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s extensive manufacturing and global commercial capabilities.

ARTICLES OF INTEREST

National Institutes of Health
|
January 14, 2024

Updates from product development and small business programs

Bio
|
December 11, 2023

The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the biotech industry, to fill the role of the organization’s new CEO.

Vertex Pharmaceuticals and bluebird bio
|
December 11, 2023

Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two milestone treatments: Casgevy, made by Vertex Pharmaceuticals, and Lyfgenia, made by bluebird bio.

National Institute on Aging
|
November 12, 2023

The NIA is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2024, unless otherwise noted. 

National Institutes of Health
|
November 12, 2023

The Senate has voted to confirm President Joe Biden’s pick to run the National Institutes of Health (NIH), Dr. Monica Bertagnolli, filling the director spot at the country’s top medical research agency after a vacancy of almost two years.

NEWSLETTER

Newsletter
|
December 12, 2024

View the December BIOWire Newsletter now!

Newsletter
|
August 26, 2024

View the September 2024 Newsletter now!